120 related articles for article (PubMed ID: 24025106)
1. Radiolabeled probes targeting G-protein-coupled receptors for personalized medicine.
Buscombe J
Curr Pharm Des; 2014; 20(14):2329-37. PubMed ID: 24025106
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled imaging probes targeting angiogenesis for personalized medicine.
Terry SY; Rijpkema M; Abiraj K; van der Graaf WT; Oyen WJ; Boerman OC
Curr Pharm Des; 2014; 20(14):2293-307. PubMed ID: 24025101
[TBL] [Abstract][Full Text] [Related]
3. Radiolabelled probes targeting infection and inflammation for personalized medicine.
Signore A; Lauri C; Galli F
Curr Pharm Des; 2014; 20(14):2338-45. PubMed ID: 24025100
[TBL] [Abstract][Full Text] [Related]
4. Radiolabeled probes targeting tyrosine-kinase receptors for personalized medicine.
Altai M; Orlova A; Tolmachev V
Curr Pharm Des; 2014; 20(14):2275-92. PubMed ID: 24025099
[TBL] [Abstract][Full Text] [Related]
5. Radiolabelled probes targeting tumor hypoxia for personalized medicine.
Mees G; Sathekge M; Maes A; Van de Wiele C
Curr Pharm Des; 2014; 20(14):2308-18. PubMed ID: 24025104
[TBL] [Abstract][Full Text] [Related]
6. Opinion Paper: Modular Drug Delivery Systems for Personalized Oral Dosage Forms.
Colombo P
Recent Pat Drug Deliv Formul; 2016; 10(1):3. PubMed ID: 26063397
[No Abstract] [Full Text] [Related]
7. Nanochannel systems for personalized therapy and laboratory diagnostics.
Grattoni A; Fine D; Ziemys A; Gill J; Zabre E; Goodall R; Ferrari M
Curr Pharm Biotechnol; 2010 Jun; 11(4):343-65. PubMed ID: 20199382
[TBL] [Abstract][Full Text] [Related]
8. Peptide-based targeted therapeutics and apoptosis imaging probes for cancer therapy.
Vadevoo SMP; Gurung S; Khan F; Haque ME; Gunassekaran GR; Chi L; Permpoon U; Lee B
Arch Pharm Res; 2019 Feb; 42(2):150-158. PubMed ID: 30756310
[TBL] [Abstract][Full Text] [Related]
9. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
[TBL] [Abstract][Full Text] [Related]
10. [Imaging in clinic and research: contribution to individualized medicine?].
Schober O; Dössel O; Ermert H; Requardt H; Ziegler S; Adam G
Nuklearmedizin; 2017; 56(5):157-161. PubMed ID: 29533421
[No Abstract] [Full Text] [Related]
11. G protein-coupled receptors: from ligand identification to drug targets. 14-16 October 2002, San Diego, CA, USA.
Chantry D
Expert Opin Emerg Drugs; 2003 May; 8(1):273-6. PubMed ID: 14610927
[TBL] [Abstract][Full Text] [Related]
12. Note: Magnetic targeting for enhancement of the activation efficiency of G protein-coupled receptor with a two-pair coil system.
Cao Q; Han X; Chun L; Liu J; Li L
Rev Sci Instrum; 2016 Jan; 87(1):016103. PubMed ID: 26827364
[TBL] [Abstract][Full Text] [Related]
13. Radiolabeled bombesin derivatives for preclinical oncological imaging.
Ferreira CA; Fuscaldi LL; Townsend DM; Rubello D; Barros ALB
Biomed Pharmacother; 2017 Mar; 87():58-72. PubMed ID: 28040598
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic potential of G-protein coupled receptors in Huntington's disease.
Dowie MJ; Scotter EL; Molinari E; Glass M
Pharmacol Ther; 2010 Nov; 128(2):305-23. PubMed ID: 20708032
[TBL] [Abstract][Full Text] [Related]
15. Small flexible structure for targeted delivery of therapeutic and imaging moieties in precision medicine.
Hu S; Wang W; Zhang Y; Li B; Qiu X; Zou C; Ran H; Zhang F; Ke S
Oncotarget; 2016 May; 7(18):25535-48. PubMed ID: 27027441
[TBL] [Abstract][Full Text] [Related]
16. Probing the pharmacology of G protein-coupled receptors with fluorescent ligands.
Stoddart LA; Kilpatrick LE; Briddon SJ; Hill SJ
Neuropharmacology; 2015 Nov; 98():48-57. PubMed ID: 25979488
[TBL] [Abstract][Full Text] [Related]
17. Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases.
Patel SK; Janjic JM
Theranostics; 2015; 5(2):150-72. PubMed ID: 25553105
[TBL] [Abstract][Full Text] [Related]
18. Nucleic acid targeting: towards personalized therapy for head and neck cancer.
Parsel SM; Grandis JR; Thomas SM
Oncogene; 2016 Jun; 35(25):3217-26. PubMed ID: 26592450
[TBL] [Abstract][Full Text] [Related]
19. TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders.
Tiwari A; Maiti P
Drug Discov Today; 2009 May; 14(9-10):523-30. PubMed ID: 19429513
[TBL] [Abstract][Full Text] [Related]
20. Toward fluorescent probes for G-protein-coupled receptors (GPCRs).
Ma Z; Du L; Li M
J Med Chem; 2014 Oct; 57(20):8187-203. PubMed ID: 24983484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
